Skip to main
CCAP
CCAP logo

CCAP Stock Forecast & Price Target

CCAP Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Crescent Capital BDC reported a significant net growth of $27 million, surpassing expectations of $10 million, indicating a robust performance relative to forecasts. Additionally, the decline in KBW watchlist investments to 1.2% from 3.1% of cost suggests an improvement in the overall credit quality of the portfolio. Although there was an increase in non-accruals and investments rated below expectations, the positive net growth and improved metrics related to watchlist investments contribute to an optimistic outlook for the company.

Bears say

Crescent Capital BDC's net asset value (NAV) experienced a decline of $0.36, or 1.8%, falling to $19.62, primarily due to net portfolio losses and operating earnings that were insufficient to cover dividends paid. The company faces significant risk factors, particularly related to credit issues that could exceed expectations, further threatening its earnings, book value, and stock price. Although total non-accruals are currently at a manageable level of 3.3% at cost value, the rapid deterioration of several recent non-accruals raises concerns about the overall stability of the company's investment portfolio.

CCAP has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Crescent Capital BDC Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Crescent Capital BDC Inc (CCAP) Forecast

Analysts have given CCAP a Buy based on their latest research and market trends.

According to 4 analysts, CCAP has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Crescent Capital BDC Inc (CCAP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.